At the moment, a lot of people in the US opt to get a covid vaccination around the time they get their annual flu jab. Each ...

The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.

For many Americans, it's not clear how easy getting a COVID-19 vaccination this fall will be — or if they've lost the choice.

AbbVie has claimed FDA approval for Emblaveo ... are paid a fixed annual fee for access to their drugs even if they are not used. That approach has been pioneered in the UK, and a federal ...

If coronavirus vaccines are restricted to seniors and those at high risk, parents of young children and relatives of ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

Novartis has a third FDA-approved indication for its oral therapy for complement-mediated diseases – Fabhalta – after getting a green light in ultra-rare kidney disease C3 glomerulopathy (C3G).

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Health Secretary Robert F Kennedy Jr. announced that CDC recommendations for COVID vaccines will no longer include healthy pregnant women and healthy children.

Health Secretary Robert F. Kennedy Jr. upended decades of standard protocol in announcing that the vaccine would be dropped ...